Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viatris Inc
(NQ:
VTRS
)
9.860
+0.050 (+0.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 29, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,367,247
Open
9.840
Bid (Size)
9.850 (6)
Ask (Size)
9.990 (1)
Prev. Close
9.810
Today's Range
9.840 - 10.03
52wk Range
8.460 - 12.40
Shares Outstanding
1,212,301,241
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Could Viatris Stock Help You Become a Millionaire?
September 30, 2023
Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?
Via
The Motley Fool
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
September 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Performance
YTD
-13.36%
-13.36%
1 Month
-8.28%
-8.28%
3 Month
-0.30%
-0.30%
6 Month
+2.60%
+2.60%
1 Year
+15.73%
+15.73%
More News
Read More
Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report
September 26, 2023
Via
Benzinga
NASDAQ: VTRS Shareholder Notice Investigation over Potential Wrongdoing by Certain Directors of Viatris Inc.
September 22, 2023
Via
SBWire
'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase
September 22, 2023
Via
Benzinga
Viatris Stock: Bear vs. Bull
August 31, 2023
Via
The Motley Fool
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
August 24, 2023
Via
The Motley Fool
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks
September 14, 2023
Via
The Motley Fool
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
September 09, 2023
Via
The Motley Fool
CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know
September 01, 2023
Via
The Motley Fool
VIATRIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Viatris Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 22, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Where Will Viatris Be in 5 Years?
August 18, 2023
Via
The Motley Fool
2 Beaten-Down Dividend Stocks to Buy
August 11, 2023
Via
The Motley Fool
Is Viatris Stock Good for Dividend Income?
August 09, 2023
Via
The Motley Fool
A Preview Of Viatris's Earnings
August 04, 2023
Via
Benzinga
Viatris Could Soon Make a Generic Ozempic, But Does That Make It a Buy?
August 16, 2023
Via
The Motley Fool
If You'd Invested $25,000 in Viatris in 2020, This Is How Much You Would Have Today
August 11, 2023
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Viatris Q2 Earnings Beat Estimates, Multiple Sclerosis Therapy Accepted For FDA Review
August 07, 2023
Via
Benzinga
Elanco Animal Health, Sovos Brands, Veritiv, Graham And Other Big Stocks Moving Higher On Monday
August 07, 2023
Via
Benzinga
Want $1,500 in Annual Passive Income? Invest This Much in Viatris Stock Each Month for 5 Years
August 04, 2023
Via
The Motley Fool
Viatris Stock: Bull vs. Bear
July 22, 2023
Via
The Motley Fool
Daily Stock Analysis: Viatris
July 20, 2023
Via
Talk Markets
Better Pharma Buy: Viatris vs. Pfizer
July 19, 2023
Via
The Motley Fool
1 Reason I Wouldn't Buy This High-Yielding Dividend Stock
July 20, 2023
Via
The Motley Fool
A Look Into Healthcare Sector Value Stocks
July 17, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.